SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-23-001376
Filing Date
2023-05-26
Accepted
2023-05-26 16:51:21
Documents
65
Period of Report
2022-11-30

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20221130x10k.htm   iXBRL 10-K 1955615
  Complete submission text file 0001410578-23-001376.txt   8272855

Data Files

Seq Description Document Type Size
2 EX-101.SCH tmb-20221130.xsd EX-101.SCH 74203
3 EX-101.CAL tmb-20221130_cal.xml EX-101.CAL 51823
4 EX-101.DEF tmb-20221130_def.xml EX-101.DEF 277103
5 EX-101.LAB tmb-20221130_lab.xml EX-101.LAB 573472
6 EX-101.PRE tmb-20221130_pre.xml EX-101.PRE 436210
59 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20221130x10k_htm.xml XML 1286767
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-K | Act: 34 | File No.: 000-55535 | Film No.: 23969893
SIC: 2834 Pharmaceutical Preparations